| 1 |
Neutral Lipid Storage Disease Associated with the PNPLA2 Gene: Case Report and Literature Review.
61
|
Samukawa M...Kusunoki S
|
32564019 |
2020 |
| 2 |
A historical case of primary triglyceride deposit cardiomyovasculopathy.
61
|
Tanaka M...Hirano KI
|
31854040 |
2020 |
| 3 |
Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.
61
|
Li M...Japan TGCV study group
|
31186072 |
2019 |
| 4 |
Intractable Coronary Artery Disease in a Patient With Type 2 Diabetes Presenting With Triglyceride Deposit Cardiomyovasculopathy.
61
|
Kozawa J...Hirano KI
|
30862655 |
2019 |
| 5 |
Tricaprin Rescues Myocardial Abnormality in a Mouse Model of Triglyceride Deposit Cardiomyovasculopathy.
61
|
Suzuki A...Hirano KI
|
30012901 |
2018 |
| 6 |
Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy.
61
|
Takagi A...Hirano KI
|
29146190 |
2018 |
| 7 |
Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study.
61
|
Nakanishi T...Kato S
|
24836730 |
2014 |
| 8 |
Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.
61
|
Pellegrino R...Brusasco V
|
25039769 |
2014 |
| 9 |
A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
61
|
Kaneko K...Aoki M
|
24836204 |
2014 |
| 10 |
Coronary triglyceride deposition in contemporary advanced diabetics.
61
|
Ikeda Y...Ishibashi-Ueda H
|
25047503 |
2014 |
| 11 |
Peripheral leukocyte anomaly detected with routine automated hematology analyzer sensitive to adipose triglyceride lipase deficiency manifesting neutral lipid storage disease with myopathy/triglyceride deposit cardiomyovasculopathy.
61
|
Suzuki A...Hirano KI
|
27896096 |
2014 |
| 12 |
Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-γ in patients with triglyceride deposit cardiomyovasculopathy.
61
|
Hirano K...Hori M
|
24332944 |
2014 |
| 13 |
Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy.
61
|
Hara Y...Tomonaga T
|
24360150 |
2013 |
| 14 |
[Triglyceride deposit cardiomyovasculopathy].
61
|
Hirano K
|
24205734 |
2013 |
| 15 |
Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice.
61
|
Inoue T...Takayanagi R
|
23886955 |
2013 |
| 16 |
Reduced expression of adipose triglyceride lipase enhances tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB.
61
|
Inoue T...Takayanagi R
|
21828047 |
2011 |
| 17 |
A novel clinical entity: triglyceride deposit cardiomyovasculopathy.
61
|
Hirano K
|
19729869 |
2009 |
| 18 |
Triglyceride deposit cardiomyovasculopathy.
61
|
Hirano K...Matsumiya G
|
19038890 |
2008 |
| 19 |
Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir.
61
|
Goslinski T...De Clercq E
|
14565309 |
2003 |
| 20 |
Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir.
61
|
Goslinski T...Balzarini J
|
12408716 |
2002 |
| 21 |
Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study.
61
|
Golankiewicz B...de Clercq E
|
11708929 |
2001 |
Rare neurological diseases 
